IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA

DAFTAR PUSTAKA

Allen, G. (2017) . Managing acute pulmonary oedema. Australian

Prescriber, 40(2), pp. 59–63.
Azad N., Kathiravelu A., Minoosepeher S., Hebert P., and Fergusson D.,
2011. Gender differences in the etiology of heart failure: A systematic
reveiew. Journal of Geriatric Cardiology., Vol. 8, pp. 15-23.
Baker L., Meldrum K.K., Wang M., Sankula R., Vanam R., Raiesdana A.,
Tsai B., Hile K., Brown J.W., and Meldrum D.R., 2003. The Role of
Estrogen in Cardiovascular Disease. Journal of Surgical Research.,
Vol. 115, pp. 325-344.
Baxter, K. Eds. 2010. Stockley’s Drug Interactions. 9th edition. London:
Pharmaceutical Press, Inc. pp. 1123-1136
Brieger, D., Amerena, J., Attia, J., Bajorek, B., Chan, K. H., Connell, C., …
Zwar, N. (2018). National Heart Foundation of Australia and the
Cardiac Society of Australia and New Zealand: Australian Clinical
Guidelines for the Diagnosis and Management of Atrial Fibrillation
2018. Heart Lung and Circulation, 27(10), 1209–1266.
https://doi.org/10.1016/j.hlc.2018.06.1043
Cerlinskaite K., Javanainen T., Cinotti R., and Mebaza A., 2018. Acute
Heart Failure Management. Korean Circulation Journal., Vol. 48,
pp. 463-480
Circ J., 2012. Guidelines for Treatment of Acute Heart Failure. Official
Journal of the Japanese Circulation Society., Vol. 77, pp. 2157-
2201
Chalik, R. 2016. Anatomi Fisiologi Manusia, Jakarta: Badan
Pengembangan dan Pemberdayaan Sumber Daya Manusia Kesehatan.
pp. 106-110

84

SKRIPSI STUDI PENGGUNAAN DIURETIKA... DESTY A. P.

 IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
85

Chan D.C., Chen J.H., Kuo H.S., We C.J., Lu I.S., Chiu L.S., and Wu S.C.,
2012. Drug related problems (DRP) identified from geriatric
medication safety review clinis. Archives of Gerontology and
Geriatrics., Vol. 54, pp. 168-174.
Dickstein K., Cohen-Solal A., Filippatos G., McMurray J. J. V.,
Ponikowski P., Poole-Wilson P. A., Stromberg A., Veldhuisen D.,
Atar D., Hoes A. W., Keren A., Mebazaa A., Nieminen M., Priori S.
G., and Swedberg K. (2008) „ESC GUIDELINES ESC Guidelines for
the diagnosis and treatment of acute and chronic heart failure 2008 ‡
The Task Force for the Diagnosis and Treatment of Acute and
Chronic Heart Failure 2008 of the European Society of Cardiology .
Developed in collaboration with the Heart Failure Association of the
ESC ( HFA ) and endorsed by the European Society of Intensive
Care‟, pp. 2388–2442. doi: 10.1093/eurheartj/ehn309.
Farmakis D., Parissis J., Papingiotis G., and Filippatos G., 2018. Acute
heart failure: Epidemiology, classification, and pathophysiology.
Oxford University Press., pp. 1-32
Frigerio M, and Roubina E., 2005. Drugs for left ventricular remodeling in
heart failure. The Am J of Cardiol, Vol. 96, pp. 10-18
Gasteluruttia P., Shalom, I.B., Jose, E., Laura, T., Antonia, M., and Antoni,
B.G., 2011. NegativeClinical Outcames Associated With Drug
Related Problems In Heart Failure (HF) Out Patient: Impact Of A
Pharmacist In A Multi Diclipinary HF Clinic. Journal of Cardiac
Failure, Vol. 17 No 3, pp. 217-223.
Ho K.M., and Power B.M., 2010. Benefits and risks of furosemid in acute
kidney injury. The Association of Anaesthesits of Great Britain and
Ireland ., Vol. 65, pp. 283-293.
Horn, J.R., and Hansten, P.D., 2004. Hyperkalemia Due to Drug

SKRIPSI STUDI PENGGUNAAN DIURETIKA... DESTY A. P.

 IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
86

Interactions. Drug Interactions: Insight and Observations, pp. 66-

67.
Katzung B.G., Masters S.B., and Trevor A.J., 2017. Drug Use In Heart
Failure. In: Katzung B.G., Masters S.B., and Trevor A.J., (Eds),
2018. Basic & Clinical Pharmacology. 14th edition. USA : The
McGraw-Hill Companies, Inc. pp. 212-216, 220.
KEMENKES RI. 2013. Pusat Data dan Informasi Kementrian Kesehatan
RI: Situasi Kesehatan Jantung. Jakarta: Kementrian Kesehatan
Republik Indonesia.
Kemp, C. D. and Conte, J. V (2012) „The pathophysiology of heart failure‟,
Cardiovascular Pathology. Elsevier Inc., 21(5), pp. 365–371. doi:
10.1016/j.carpath.2011.11.007.
Mariyono, H.H., and Santoso, A., 2004. Gagal Jantung. J Peny Dalam.,
Vol. 8, pp. 86-94.
McMurray J., Adamopoulos S., Anker S., Auricchio A., Bohm M.,
Dicsktein K., Falk V., Fillipatos G., Fonseca C., Gomez-Sanchez M.,
Jaarsma T., Kober L., Lip G., Maggioni A., Parkhomenko A., Pieske
B., Popescu B., Ronnevik P., Rutten F., Schwitter J., Seferovic.,
Stepsinka., Trindade P., Voors A., Zannad F., and Zeiher A., 2012.
ESC Guidelines for the diagnosis and treatment of acute and chronic
heart failure. European Heart Journal., Vol 33, pp. 1787-1847
Moini, J., 2016. Anatomy and Physiology for Health Professionals. 2nd
edition. Burlington: Jones & Barlett Learning. pp. 371-381.
Musini V.N., Nazer M., Basset K., and Wright J.M., 2014. Blood pressure-
lowering efficacy of monotherapy with thiazide diuretics for primary
hypertension. The Cochrane Collaboration., Issue. 5, pp. 1-174.
Muti A.F., and Chasanah U., 2016. Evaluasi Rasionalitas Penggunaan
Diuretik pada Pasien Gagal Ginjal Kronik yang Dirawat Inap di

SKRIPSI STUDI PENGGUNAAN DIURETIKA... DESTY A. P.

 IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
87

RSUD Dr. Saiful Anwar Malang. Sainstech Farma., Vol. 9, pp. 23-
31.
Nafrialdi and Setiawati, 2016. Diuretik dan Antidiuretik. In: Gunawan,
Sulistia G. et.al., 2016. Farmakologi dan Terapi. Edisi ke-6, Jakarta:
Badan penerbit FKUI. pp. 310-311.
Nafrialdi and Soetikno, 2016. Obat Gagal Jantung. In: Gunawan, Sulistia
G. et.al., 2016. Farmakologi dan Terapi. Edisi ke-6, Jakarta: Badan
penerbit FKUI. pp. 396-412.
Nathnia M., 2019. Hipokalemia – Diagnosis dan Tatalaksana. CDK., Vol.
46, pp. 103-108.
Neal, M.J. Eds. 2012. At a Glance Medical Pharmacology. 7th edition.
London: Blackwell Publishing Company, Inc. pp. 34-35.
Niaminen M., Bohm M., Cowie M., Drexler H., Filippatos G., Jondeau G.,
Hasin Y., Lopez-Sendon J., Mebazza A., Metra M., Rhodes A., and
Swedberg K., 2005. Guidelines on the diagnosis and treatment of
acute heart failure. The European Society of Cardiology., pp. 1-36
Oh S.W., and Han S.Y., 2015. Loop Diuretics in Clinical Practice.
Electrolyte Blood Press., Vol. 13, pp. 17-21.
Parker, et al., 2017. Heart Failure. In: Dipiro, Joseph T. et.al., 2017.
Pharmacotherapy A Pathophysiologic Approach. 10th edition. The
McGraw-Hill Companies, Inc. pp. 565-567.
Paterna S., Parrinello G., Cannizzaro S., Fasullo S., Paterna S., Torres D.,
Sarullo F.M., and Di Pasquale P., 2009. Medium Term Effects of
Different Dosage of Diuretic, Sodium, and Fluid Administration on
Neurohormonal and Clinical Outcome in Patient With Recently
Compensated Heart Failure. Elsavier Inc., Vol. 103, pp. 93-102.
PERKI. 2015. Pedoman Tatalaksana Gagal Jantung. Edisi ke-1,
Indonesia: Perhimpunan Dokter Spesialis Kardiovaskular Indonesia.

SKRIPSI STUDI PENGGUNAAN DIURETIKA... DESTY A. P.

 IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
88

Ponikowski, P., Anker, S. D., AlHabib, K. F., Cowie, M. R., Force, T. L.,
Hu, S., … Filippatos, G. (2014). Heart failure: preventing disease and
death worldwide. ESC Heart Failure, 1(1), 4–25.
https://doi.org/10.1002/ehf2.12005.
Ponikowski, P., Anker, S. D., Voors, A. A., Bueno, H., Cleland, J. G. F.,
Coats, A., … Filippatos, G. (2016). 2016 ESC Guidlines for the
diagnosis and treatment of acute and chronis heart failure. ESC Heart
Failure, Vol. 37, pp. 2129-2200.
Rosano G. MC., Vitale C., and Seferovic P., 2011. Heart Failure in Patients
with Diabetes Mellitus. : Cardiac Failure Review., Vol. 3, pp. 52-55.
Ross A., Hershberger R. E., and Ellison D. H. 2006. Diuretics in congestive
heart failure. In: Feldman, Arthur F. et.al., 2006. Heart Failure :
Pharmalocigal Management. London: Blackwell Publishing
Company, Inc. pp. 1-4.
Sachdeva, P.D., and Patel, B.G., 2010. Drug Utilization Studies-Scope and
Future Perspectives. International Journal on Pharmaceutical and
Biological Research., Vol. 1, pp. 11-17.
Salvador D.R.K., Rey N.R., Ramos G.C., and Punzalan F.E.R., 2005.
Continuous infusion versus bolus injection of loop diuretics in
congestive heart failure (Review). The Cochrane Collaboration.,
Vol. 2, pp. 1-7.
Sam R., Ives H. E., and Pearce D. 2017.Diuretics Agent. In: Katzung B.G.,
Masters S.B., and Trevor A.J., (Eds), 2018. Basic & Clinical
Pharmacology. 14th edition. USA : The McGraw-Hill Companies,
Inc. pp. 262-267.
Scanlon, Valerie C., Sanders, Tina., 2007. Essentials of Anatomy and
Physiology. 5th edition. USA: F.A. Davis Company. pp. 273-283.
Schepkens, H., Raymond, V., JEan, M.B., and Norbert, L., 2001.

SKRIPSI STUDI PENGGUNAAN DIURETIKA... DESTY A. P.

 IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
89

Lifethreatening Hyperkalemia during Combined Therapy with

Angiotensinconverting Enzyme Inhibitors and Spironolactone: An
Analysis of 25 Cases. The American Journal Medicine., Vol. 110,
pp. 438-441.
Schoen F. Heart Failur. In: Kumar V, Abbas AK, Fausto N. Robbins and
cotran pathologic basic disease. USA: Elsavier, Inc.; 2005. p. 560
Schwinghammer, T.L., 2015. Heart Failure. In: Dipiro, Joseph T. et.al.,
2015. Pharmacotherapy A Pathophysiologic Approach. 9th edition.
The McGraw-Hill Companies, Inc. pp. 75-78.
Shalini, S., Ravichandran V., Mohanty B. K., Dhanaraj S. K., and
Saraswathi R. 2010. Drug Utilization Studies - An Overview.
International Journal of Pharmaceuticals Sciences and
Nanotechnology., Vol. 3, pp. 804-810.
Smellie W.S.A., Forth J., Coleman J.J., Irvine W., Dore P.C., Handley G.,
Williams D.G., Galloway P.J., Kerr K.G., Herriot R., Spickett G.P.,
and Reynolds T.M., 2007. Best practice in primary care pathology :
review 6. J Clin Pathol. Vol. 60, pp. 225-234.
Sudarta, I.W. 2013. Asuhan Keperawatan Klien dengan Gangguan Sistem
Cardiovascular. Yogyakarta: Gosyen Publishing.
Sutherland, K. (2010). Bridging the quality gap: Heart failure - The Health
Foundation. Retrieved from
www.health.org.uk/sites/health/files/BridgingTheQualityGapHeartFai
lure_0.pdf.
Tatro, D.S., 2009. Drug Interaction Facts. Wolsters Kluwes Health, Inc.
Ural D., Cavusoglu Y., Eren M., KArauzum K., Temizhan A., Yilmaz M.,
Zoghi M., Ramassubu K., and Bozkurt B., 2015. Diagnosis and
management of heart failure. Turkish Society of Cardiology., Vol.
15, pp 860-869

SKRIPSI STUDI PENGGUNAAN DIURETIKA... DESTY A. P.

 IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA
90

Vardeny O., Ng.TeanM.H, 2016. Pharmacotheraphy : A Pathophysiology

Approach. 4th Edition. United States of America: The McGraw-Hill
Companies, Inc. pp. 65-90.
Voors, Adrian A., Ponikowski, P., Anker, Stefan D., et all (2016). ESC
Guidelines for the diagnosis and treatment of acute and chronic heart
failure 2016. European Heart Journal., Vol. 37, pp. 2129-2200.
Watson, R. D. S. (2000). ABC of heart failure: Clinical features and
complications. Bmj, 320(7229), 236–239.
https://doi.org/10.1136/bmj.320.7229.236.
Wheinhaus, A. J., 2009. Handbook of Cardiac Anatomy, Physiology, and
Devices. 3rd edition. USA: Springer International Publishing. pp. 61-
77.
Whitaker, R. H. (2014) „Anatomy of the heart‟, Medicine. Elsevier Ltd,
42(8), pp. 406–408. doi: 10.1016/j.mpmed.2014.05.007.
WHO., 2003. Introduction to Drug Utilization Research, Norway: World
HEalth Organization.
Yancy, Clyde W., Jessup, M., Bozkurt, B., Butler, J., et all (2017). 2017
ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guidline
for the Management of Heart Failure. Journal of the American
College of Cardiology. Vol. 62, pp. 1495-1539.
Yancy, Clyde W., Jessup, M., Bozkurt, B., Butler, J., et all (2017). 2013
ACCF/AHA Guidline for the Management of Heart Failure:
Executive Summary. Journal of the American College of
Cardiology. pp. 137-161.

SKRIPSI STUDI PENGGUNAAN DIURETIKA... DESTY A. P.